FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

eirik torheim

Research Profile

Concepts & Ideas

T-Lymphocyte Subsets

Anatomy

Living Beings

HIV-1

Physiology

Cell Proliferation

Disorders

Chemicals & Drugs

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Frank O Pettersen; Per M Sandset; Kjetil Taskén; eirik torheim; Ingeborg S Aaberge; Einar M Aandahl; Anders E A Dahm; Malin Holm; Andreas Lind; Dag Kvale
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.
Lishomwa C Ndhlovu; Fabio E Leal; Ijeoma G Eccles-James; Aashish R Jha; Marion Lanteri; Philip J Norris; Jason D Barbour; Douglas J Wachter; Jan Andersson; Kjetil Taskén; eirik torheim; Einar M Aandahl; Esper Kallas; Douglas F Nixon
A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.
eirik torheim; Elisabeth Jarnaess; Birgitte Lygren; Kjetil Taskén
Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of eirik torheim (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2011: Frank O Pettersen; Per M Sandset; Kjetil Taskén; eirik torheim; Ingeborg S Aaberge; Einar M Aandahl; Anders E A Dahm; Malin Holm; Andreas Lind; Dag Kvale
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.
Journal of virology 2011;85(13):6557-66.
2010: Lishomwa C Ndhlovu; Fabio E Leal; Ijeoma G Eccles-James; Aashish R Jha; Marion Lanteri; Philip J Norris; Jason D Barbour; Douglas J Wachter; Jan Andersson; Kjetil Taskén; eirik torheim; Einar M Aandahl; Esper Kallas; Douglas F Nixon
A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.
European journal of immunology 2010;40(1):134-41.
2009: eirik torheim; Elisabeth Jarnaess; Birgitte Lygren; Kjetil Taskén
Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling.
The Biochemical journal 2009;424(1):69-78.
2009: eirik torheim; Lishomwa C Ndhlovu; Frank O Pettersen; Trine-Lise Larsen; Aashish R Jha; Knut Martin Torgersen; Dag Kvale; Douglas F Nixon; Kjetil Taskén; Einar M Aandahl
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.
European journal of immunology 2009;39(5):1280-7.
2005: eirik torheim; Arne Yndestad; Vigdis Bjerkeli; Bente Halvorsen; Pål Aukrust; Stig S Frøland
Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro.
Clinical and experimental immunology 2005;140(2):376-83.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.